Kibow Biotech, Inc.

[On Demand]
Kibow Biotech is a Clinical stage biotechnology company pioneering the development and commercialization of scientifically formulated probiotics and prebiotics (synbiotics) to support kidney health. Its flagship product Renadyl™ has three proprietary probiotic strains to metabolize uremic toxins and restore the healthy gut microbiome. Withpharmaceutical-like validation, extensive R&D, including safety dose-escalation clinical trials and efficacy clinical trials in CKD and dialysis patients, Renadyl™ offers a safer alternative to drugs to avoid adverse reactions and side effects. Kibow’s mission is toprovide convenient and efficacious kidney health products to CKD patients. With the FDA's recent approval of our IND for US-APR2020, Kibow Biotech hopes to transition Renadyl from a kidney health supplement to a Live Biotherapeutic Product(LBP) drug under the Center for Biologics Evaluation and Research (CBER) and USFDA regulations.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Live Biotherapeutic Product drug
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Managing Director
Kibow Biotech, Inc